Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
about
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expressionSAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinomaBPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cellsCombination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expressionEpstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activationSalt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death.A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivationDifferential baseline and response profile to IFN-gamma gene transduction of IL-6/IL-6 receptor-alpha secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture.Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell linesUpregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator ZtaChronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways.Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma.Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent mannerBerberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblastsOncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells.Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area.Epstein-Barr virus-associated gastric adenocarcinoma.Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking AutophagyPharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.
P2860
Q24628370-598EF9AF-72E4-4458-90AE-C4D12D4EAFEBQ28235586-AF0C1D76-8E50-4624-9780-4753991EA9BCQ28476664-057289A0-5500-424E-B457-5B39D1296737Q28485457-D4EF3B56-0090-4F01-9EE9-47C9963BA9AEQ28728022-60592167-5414-4103-9406-C7DF07E58025Q30577179-519424EB-5845-40F6-8893-D9302512B2A7Q31117844-09979361-062B-4604-ADA4-6CDCC5AD8D0AQ33460760-6EA6AFB1-9903-4750-B663-80F5567A9E53Q33773213-E749BA2C-FA0E-4A17-A2A4-93DCDA5A3CF9Q33809585-206527C4-FFE0-4D53-8149-DEAD66D57EF6Q33818857-80D24AD2-2942-41C7-9284-FD31AB842942Q33821583-2B176CCB-2CAE-4D1B-83B3-76F51E198928Q33877497-77792C8D-0185-4557-8C0F-2E4E4341937DQ33942005-7AAFE2D9-0BD0-43FB-BC6B-B92349F00100Q34120915-1DF3750F-16C5-4C96-B973-209589531AC2Q34126659-AD6BE37D-31F7-4412-8CCE-739836A35748Q34227706-FF6F8EF2-6722-4B05-B539-55DEB7CD18E4Q34262286-06EEBA7E-E38B-4E1B-9794-676495017331Q34318060-A8B34D35-3DDA-46DD-89E3-E6E1E97F8F75Q34483687-ADD2FE79-0114-4C9F-BCE8-82AF6C693EE3Q34586675-29B9933D-8234-481C-B7DA-EBA097C2BBFBQ34596828-14252BF4-DD50-4ADD-A8CB-D0E8D021B2E4Q35001181-48A5A1EE-869A-4A17-AB17-1F1E095737B2Q35032548-30972801-BF69-409B-A0E6-50B773798894Q35076801-303E4857-9E21-41A9-BC78-BDA5D797BBB7Q35079161-4526BDDE-4C9D-4F81-9423-B7E7CF3DF741Q35080861-CE9BB128-EA73-41F9-A2A9-B6E9970121A3Q35138905-F9A2D051-411F-46DC-8532-77F1FF846B98Q35157443-CF89417F-46F4-4BF0-9623-3922615B3CBFQ35505126-F92E30D9-429B-4B39-8C2A-1E247DEEE247Q35598260-38ABC859-9CFA-49EC-A53B-043CFA9BD41AQ35606754-0463786D-4DBC-45A1-BC67-915F40D5061EQ35764233-4DAE0F26-5589-41CC-BEC2-ADE641410673Q35826192-70BD71D4-AAE6-4627-AB74-ED3E7BEE7E3CQ35826481-43129DAD-FB78-47B2-B12B-BBCC8F021609Q35831281-BE697B40-6D35-4924-94C6-96B8A147626AQ35832355-F8D7D792-0FDE-42EC-960E-7637B9A7D340Q36164237-596D6043-D1A3-48C3-9895-B3106BAA724EQ36208147-B677BB1F-8D85-4411-8F88-C90EB153593BQ36356243-9EFC256D-D0B9-4A8A-B73D-37FD9C16A9E0
P2860
Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@ast
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@en
Two epithelial tumor cell lines
@nl
type
label
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@ast
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@en
Two epithelial tumor cell lines
@nl
prefLabel
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@ast
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@en
Two epithelial tumor cell lines
@nl
P2093
P2860
P4510
P921
P356
P1476
Two epithelial tumor cell line ...... rom nasopharyngeal carcinomas.
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.23.9524
P407
P577
1989-12-01T00:00:00Z